Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 83
Drug Discovery 76
Optical 72
Optical Disorders Drugs 68
Immune Disorders Drugs 68
Cardiovascular Drugs 45
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 36
Dermatological Drugs 35
Biotechnology 30
Genomics 28
Clinical Trials 23
Pharmaceuticals 22
Endocrine and Metabolic Disorders Drugs 22
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Allergy and Immunology 16
Respiratory Drugs 16
Infusions and Injectables 14
Drugs by Therapeutic Area 13
Gastrointestinal Drugs 13
Allergy Drugs 13
Lung Cancer Drugs 11
Oncology 10
Dermatology 9
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Asthma Drugs 8
Diagnostics 7
Biosimilars and Biosuperiors 7
Pharmaceutical Manufacturing 7
Analgesics 6
Enzymes 6
Prostate Cancer Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Cardiovascular Devices 4
Drug Delivery 4
Vaccines 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

670 Results (Page 19 of 34)
- Relevance
  Sort by

CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025

 Report
April 2025
220 Pages
Global

From

€1763EUR$1,997USD£1,528GBP

Ophthalmic Drugs Market by Product Type (Over-The-Counter Drugs, Prescription Drugs), Drug Class (Anti-Allergics, Anti-Glaucoma Agents, Anti-Inflammatories), Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast 2025-2030

 Report
August 2025
187 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

Age-related Macular Degeneration Market by Treatment (Non-Pharmacological, Pharmacological), Drug Class (Anti-Vegf, Corticosteroid), Type, End User, Distribution Channel - Global Forecast 2025-2030

 Report
August 2025
191 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

 Report
November 2024
716 Pages
Global

From

€4237EUR$4,799USD£3,673GBP

Non-small Cell Lung Cancer Drugs Market 2023-2027

 Report
May 2023
167 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Postpartum Depression Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Skeletal Dysplasia - Global Strategic Business Report

 Report
August 2025
378 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Human Gene Sequencing Markets, Strategies & Trends: Forecasts By Application, By Technology, By Workflow, By Product, and By Country with Executive and Consultant Guides

 Report
August 2025
835 Pages
Global

From

€6176EUR$6,995USD£5,354GBP

Whole Genome and Exome Sequencing Market: By Application, Organism and Product with Executive and Consultant Guides

 Report
August 2025
681 Pages
Global

From

€6176EUR$6,995USD£5,354GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
August 2025
385 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021

 Clinical Trials
October 2021
121 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
August 2025
262 Pages
Global

From

€6176EUR$6,995USD£5,354GBP

Central Nervous System Collaboration and Licensing Deals 2020-2025

 Report
April 2025
400 Pages
Global

From

€3527EUR$3,995USD£3,058GBP

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

 Report
February 2025
222 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Lysosomal Acid Lipase Deficiency Treatment - Global Strategic Business Report

 Report
August 2025
279 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Pruritus Therapeutics Market by Therapy (Antihistamines, Biologics, Calcineurin inhibitors), Route of Administration (Injectable, Oral, Topical), Disease Indication, Patient Demographics, Distribution Channel, End-User - Global Forecast 2025-2030

 Report
August 2025
194 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

Facial Erythema Treatment Market 2024-2028

 Report
November 2024
156 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Viral Vector Collaboration and Licensing Deals 2016-2025

 Report
May 2025
250 Pages
Global

From

€3527EUR$3,995USD£3,058GBP

Pulmonary Embolism Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

670 Results (Page 19 of 34)
- 1
- 17
- 18
- 19
- 20
- 21

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.